Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B
dc.article.end-page | 3057 | en |
dc.article.start-page | 3049 | en |
dc.citation.doi | 10.1182/BLOODADVANCES.2022009230 | en |
dc.contributor.author | A Shapiro | en |
dc.contributor.author | R Kulkarni | en |
dc.contributor.author | M Ragni | en |
dc.contributor.author | H Chambost | en |
dc.contributor.author | Johnny Mahlangu | en |
dc.contributor.author | E et al | en |
dc.date.accessioned | 2024-07-23T05:54:05Z | |
dc.date.available | 2024-07-23T05:54:05Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 2473-9529 | en |
dc.identifier.uri | https://hdl.handle.net/10539/39018 | |
dc.journal.title | Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B | en |
dc.journal.volume | 7 | en |
dc.title | Post hoc longitudinal assessment of the efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 216.04 KB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client